Photo of Martin Henriksson

Martin Henriksson

Associate Professor, Docent

My work is primarily focused on research and education related to health economic evaluations. I want to contribute to methodological development as well as ensuring that a coherent and appropriate approach to health economic evaluations is pursued.

Health economic evaluations - an important tool to support decisions on how to allocate health care resources

The purpose of health economic evaluations is to estimate costs and health consequences of interventions in health-care sector. Interventions can encompass surgical procedures, pharmaceutical treatments, diagnostic procedures as well as prevention programs. In my work I focus primarily on applied economic evaluation, and how evaluations appropriately can inform decision making in health-care sector.

Health economic evaluations

What are the requirements of a relevant and appropriate economic evaluation of a health intervention, and which practical methods can lead us towards meeting these requirements? These are key questions in my work and I am particularly interested in the role of models and clinical trials in practical evaluations. Key aspects such as extrapolation, evidence synthesis, handling of uncertainty and assessing the value of further research are all part of my research interests.

Health policy and implications for economic evaluations

The role of economic evaluations within the health policy and health-care decision making is continuously debated. The Swedish health-care system has several layers of decision making including the national level with the Dental and pharmaceutical benefit agency (TLV) making decisions on drug reimbursement, and bodies like the National board of health and welfare and the SBU issuing guidelines on a national level. There are also regional and local levels of decision making at the level of county councils, hospitals and specific clinics. Health economic evaluations in some shape and form are used at all levels of decision making, although one may argue that there is a lock of consistency in their use across the levels. In my work I seek to understand how these levels are interlinked and what the implications would be for health economic evaluation methodology.

Recent publications


Lina Gruneau, Stergios Kechagias, Per Sandström, Mattias Ekstedt, Martin Henriksson (2023) Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease HEPATOLOGY COMMUNICATIONS, Vol. 7, Article e00191 Continue to DOI
Karin Johansen, Anna Lindhoff Larsson, Linda Lundgren, Thomas Gasslander, Claes Hjalmarsson, Per Sandström, Johan Lyth, Martin Henriksson, Bergthor Björnsson (2023) Laparoscopic distal pancreatectomy is more cost-effective than open resection: results from a Swedish randomized controlled trial HPB, Vol. 25, p. 972-979 Continue to DOI
Hannes Runheim, Maria Pettersson, Anna Hammarsjo, Ann Nordgren, Martin Henriksson, Anna Lindstrand, Lars-Åke Levin, Maria Johansson Soller (2023) The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders Scientific Reports, Vol. 13 Continue to DOI
Kajsa Appelberg, Lene Sorensen, Rolf H. Zetterstrom, Martin Henriksson, Anna Wedell, Lars-Åke Levin (2023) Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism The Journal of Pediatrics, Vol. 256, p. 38-43.e3 Continue to DOI
Kasper Johannesen, Jonathan Siverskog, Martin Henriksson, Magnus Janzon, Bertil Lindahl, Erik Groenqvist (2023) Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 12 Continue to DOI

Research interests

Research affiliation